PolyPeptide shortlists EQT and IDG Capital as bidding process advances
PolyPeptide Group has narrowed the field of potential buyers for its next auction phase, selecting private equity firms EQT AB and IDG Capital to move forward in the bidding process for the Swiss contract drug manufacturer, according to a report by Bloomberg.
Original Source
Read the full article at Privateequitywire →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.